Skip to content

Clinical trials

Phase 2 Premature Birth trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 2 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20142
20191
20202
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Not yet recruiting2
Withdrawn2
Unknown status1
Recruiting1
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hamilton Health Sciences Corporation2
Aerogen Pharma Limited1
CHU de Quebec-Universite Laval1
Dr. Michael Dunn1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Ottawa Hospital Research Institute1
Queen's University1
Sir Mortimer B. Davis - Jewish General Hospital1
Sunnybrook Health Sciences Centre1
The Hospital for Sick Children1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth12
Bronchopulmonary Dysplasia2
Enterocolitis, Necrotizing2
Respiratory Distress Syndrome2
Abortion, Spontaneous1
Ductus Arteriosus, Patent1
Fetal Growth Retardation1
Hyaline Membrane Disease1
Intestinal Diseases1
Pre-Eclampsia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.